Skip Navigation

European Heart Journal 2001 22(17):1527-1560; doi:10.1053/euhj.2001.2783
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Swedberg, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swedberg, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Task Force Report

Guidelines for the diagnosis and treatment of chronic heart failure

Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology, W. J. Remme, Co-Chairmanf1 and K. Swedberg, Co-Chairman

Received May 1, 2001; accepted May 2, 2001

f1 Correspondence: Professor Willem J. Remme, Sticares Cardiovascular Research Foundation, "Oeverstate", Oever 7, P.O. Box 882, 3160 AB, Rhoon, The Netherlands. Professor Karl Swedberg, Göteborg University, Department of Medicine, Sahlgrenska University Hospital, SE-416 85 Göteborg, Sweden.

References

  1. Eur Heart J. 1995;16:741–751
  2. Eur Heart J. 1997;18:736–753
  3. Cowie MR, Struthers AD, Wood DA. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet. 1997;350:1349–1353
  4. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441–1446
  5. McMurray J, McDonagh T, Morrison CE, Dargie HJ. Trends in hospitalization for heart failure in Scotland 1980–1990. Eur Heart J. 1993;14:1158–1162
  6. Murdoch DR, Love MP, Robb SD. Importance of heart failure as a cause of death. Changing contribution to overall mortality and coronary heart disease mortality in Scotland 1979–1992. Eur Heart J. 1998;19:1929–1935
  7. Cleland JG, Gemmell I, Khand A, Boddy A. Is the prognosis of heart failure improving? Eur J Heart Fail. 1999;1:229–241
  8. Mosterd A, Hoes AW, de Bruyne MC. Prevalence of heart failure and left ventricular dysfunction in the general population. Eur Heart J. 1999;20:447–455
  9. McDonagh TA, Morrison CE, Lawrence A. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population. Lancet. 1997;350:829–P833
  10. Cowie MR, Wood DA, Coats AJ. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83:505–510
  11. Senni M, Tribouilloy CM, Rodeheffer RJ. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med. 1999;159:29–34
  12. N Engl J Med. 1992;327:685–691
  13. MacIntyre K, Capewell S, Stewart S. Evidence of improving prognosis in heart failure: trends in case fatality in 66547 patients hospitalized between 1986 and 1995. Circulation. 2000;102:1126–1131
  14. Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med. 1993;86:17–23
  15. Remes W, Lansimies E, Pyorala K. Usefulness of M-Mode echocardiography. Cardiology. 1991;78:267–277
  16. Wood P. Heart Failure. Wood P. Diseases of the Heart and Circulation. London: Eyre and Spottiswoode; 1950.
  17. Braunwald E. Heart failure: An overview. Fishma AP. Heart Failure. New York: McGraw-Hill; 1977.
  18. Denolin H, Kuhn H, Krayenbuehl HP, Loogen F, Reale A. The definition of heart failure. Eur Heart J. 1983;4:445–446
  19. Poole-Wilson PA. Chronic heart failure causes pathophysiology, prognosis, clinical manifestations, investigation. Julian DG, Camm AJ, Fox KM, Hall RJC, Poole-Wilson P. Diseases of the Heart. London: Bailliere-Tindall; 1989.
  20. Sutton GC. Epidemiologic aspects of heart failure. Am Heart J. 1990;120:1538–1540
  21. Choudhri AH, Cleland JG, Rowlands PC, Tran TL, McCarty M, al-Kutoubi MA. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ. 1990;301:1197–1198
  22. Lipkin DP, Canepa-Anson R, Stephens MR, Poole-Wilson PA. Factors determining symptoms in heart failure: comparison of fast and slow exercise tests. Br Heart J. 1986;55:439–445
  23. Puri S, Baker BL, Oakley CM, Hughes JM, Cleland JG. Increased alveolar/capillary membrane resistance to gas transfer in patients with chronic heart failure. Br Heart J. 1994;72:140–144
  24. Poole-Wilson PA. Relation of pathophysiologic mechanisms to outcome in heart failure. J Am Coll Cardiol. 1993;22:22A–9A
  25. Coats AJ, Adamopoulos S, Meyer TE, Conway J, Sleight P. Effects of physical training in chronic heart failure. Lancet. 1990;335:63–66
  26. Caruana L, Petrie MC, Davie AP, McMurray JJ. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. BMJ. 2000;321:215–218
  27. Wilson JR, Mancini DM, Dunkman WB. Exertional fatigue due to skeletal muscle dysfunction in patients with heart failure. Circulation. 1993;87:470–475
  28. Cleland JG, Oakley CM. Vascular tone in heart failure: the neuroendocrine-therapeutic interface. Br Heart J. 1991;66:264–267
  29. Francis GS, Benedict C, Johnstone DE. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction (SOLVD). Circulation. 1990;82:1724–1729
  30. Swedberg K. Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies. Review. Eur J Heart Fail. 2000;2:229–233
  31. Mancia G, Seravalle G, Giannattasio C. Reflex cardiovascular control in congestive heart failure. Am J Cardiol. 1992;69:17G–22G
  32. Packer M. How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol. 1993;71:3
  33. Mann DL, Young JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Review. Chest. 1994;105:897–904
  34. Gadsboll N, Hoilund-Carlsen PF, Nielsen CG. Symptoms and signs of heart failure in patients with myocardial infarction: reproducibility and relationship to chest X-ray, radionuclide ventriculography and right heart catherization. Eur Heart J. 1989;10:1017–1028
  35. Marantz PR, Tobin JN, Wassertheil-Smoller S. The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria. Circulation. 1988;77:607–612
  36. Butman SM, Ewy GA, Standen JR, Kern KB, Hahn E. Bedside cardiovascular examination in patients with severe chronic heart failure: importance of rest or inducible jugular venous distension. J Am Coll Cardiol. 1993;22:968–974
  37. Stevenson LW, Perloff JK. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 1989;10:884–888
  38. Folland ED, Kriegel BJ, Henderson WG, Hammermeister KE, Sethi GK. Implications of third heart sounds in patients with valvular heart disease. The Veterans Affairs Cooperative Study on Valvular Heart Disease. N Engl J Med. 1992;327:458–462
  39. Ishmail A, Wing S, Ferguson J, Hutchinson T, Magder S, Flegel J. Interobserver agreement by ausculation in the presence of a third heart sound in patients with congestive heart failure. Chest. 1987;91:870–873
  40. Spiteri MA, Cook DG, Clarke SW. Reliability of eliciting physical signs in examination of the chest. Lancet. 1988;1:873–875
  41. van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1992;70:359–363
  42. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457–464
  43. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Pimobendan Multicenter Research Group. Am Heart J. 1992;124:1017–1025
  44. Rihal CS, Davis KB, Kennedy JW, Gersh BJ. The utility of clinical, electrocardiographic, and roentgenographic variables in the prediction of left ventricular function. Am J Cardiol. 1995;75:220–223
  45. Gillespie ND, McNeill G, Pringle T, Ogston S, Struthers AD, Pringle SD. Cross sectional study of contribution of clinical assessment and simple cardiac investigations to diagnosis of left ventricular systolic dysfunction in patients admitted with acute dyspnoea. BMJ. 1997;314:936–940
  46. Mosterd A, de Bruijne MC, Hoes AW, Deckers JW, Hofman A, Grobbee DE. Usefulness of echocardiography in detecting left ventricular dysfunction in population-based studies (The Rotterdam Study). Am J Cardiol. 1997;79:103–104
  47. Badgett RG, Lucey CR, Mulrow CD. Can the clinical examination diagnose left-sided heart failure in adults? JAMA. 1997;277:1712–1719
  48. Alam M, Rosenhamer G, Hoglund C. Comparability of echocardiography and chest X-ray following myocardial infarction. J Intern Med. 1989;226:171–175
  49. Kono T, Suwa M, Hanada H, Hirota Y, Kawamura K. Clinical significance of normal cardiac silhouette in dilated cardiomyopathy–evaluation based upon echocardiography and magnetic resonance imaging. Jpn Circ J. 1992;56:359–365
  50. Madsen EB, Gilpin E, Slutsky RA, Ahnve S, Henning H, Ross J Jr. Usefulness of the chest x-ray for predicting abnormal left ventricular function after acute myocardial infarction. Am Heart J. 1984;108:1431–1436
  51. McNamara RF, Carleen E, Moss AJ. Estimating left ventricular ejection fraction after myocardial infarction by various clinical parameters. Am J Cardiol. 1988;62:192–196
  52. Badgett RG, Mulrow CD, Otto PM, Ramirez G. How well can the chest radiograph diagnose left ventricular dysfunction? J Gen Intern Med. 1996;11:625–634
  53. Miniati M, Pistolesi M, Paoletti P. Objective radiographic criteria to differentiate cardiac, renal, and injury lung edema. Invest Radiol. 1988;23:433–440
  54. Kostuk W, Barr JW, Simon AL, Ross J Jr. Correlations between the chest film and hemodynamics in acute myocardial infarction. Circulation. 1973;48:624–632
  55. Chakko S, Woska D, Martinez H. Clinical, radiographic, and hemodynamic correlations in chronic congestive heart failure: conflicting results may lead to inappropriate care. Am J Med. 1991;90:353–359
  56. Kundel HL, Revesz G. Digital analysis of chest radiographs in pulmonary vascular congestion. Radiology. 1982;143:407–410
  57. Grover MSRA, Higgins CB, Shabetai R. Extravascular lung water in patients with congestive heart failure. Radiology. 1983;147:659–662
  58. Otterstad JE, Froeland G, St John Sutton M, Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J. 1997;18:507–513
  59. Hoglund C, Alam M, Thorstrand C. Atrioventricular valve plane displacement in healthy persons. An echocardiographic study. Acta Med Scand. 1988;224:557–562
  60. Tei C, Ling TH, Hodge DO. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J Cardiol. 1995;26:357–366
  61. Berning J, Steensgaard-Hansen F. Early estimation of risk by echocardiographic determination of wall motion index in an unselected population with acute myocardial infarction. Am J Cardiol. 1990;65:567–576
  62. Willenheimer RB, Israelsson BA, Cline CM, Erhardt LR. Simplified echocardiography in the diagnosis of heart failure. Scand Cardiovasc J. 1997;31:9–16
  63. Eur Heart J. 1998;19:990–1003
  64. Stefanadis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart J. 2001;22:22–36
  65. Pierard LA, Lancellotti P, Benoit T. Myocardial viability. Stress echocardiography vs nuclear medicine. Eur Heart J. 1997;18:D117–23
  66. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol. 1996;27:132–139
  67. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation. 1999;100:141–148
  68. Udelson JE, Bonow RO. Radionuclide angiographic evaluation of left ventricular diastolic function. Gaasch WH, LeWinter M. Left ventricular diastolic dysfunction and heart failure. Malvern: Lea & Febiger; 1994. p. 167–191
  69. Kramer CM. Integrated approach to ischemic heart disease. Reichek N. Cardiology Clinics. London: W.B. Saunders Company; 1998. p. 267–276
  70. Cook DG, Shaper AG. Breathlessness, lung function and the risk of heart attack. Eur Heart J. 1988;9:1215–1222
  71. Kannel WB, D'Agostino RB, Silbershatz H. Use of vital capacity for cardiac failure risk estimation in persons with coronary disease and left ventricular hypertrophy. Am J Cardiol. 1996;77:1155–1158
  72. McNamara RM, Cionni DJ. Utility of the peak expiratory flow rate in the differentiation of acute dyspnea. Cardiac vs. pulmonary origin. Chest. 1992;101:129–132
  73. Diamopoulon I, Tsintzas OK, Daganou M, Cokkinos D, Tzelepis GE. Contribution of lung function to exercise capacity in patients with chronic heart failure. Respiration. 1999;66:144–149
  74. Mamas S, Nanas J, Kassiotis C. Respiratory muscle performance is related to oxygen kinetics during maximal exercise and early recovery in patients with congestive heart failure. Circulation. 1999;100:503–508
  75. Eur Heart J. 2001;22:37–45
  76. Guyatt GH, Sullivan MJ, Thompson PJ. The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. CMAJ. 1985;132:919–923
  77. Bittner V, Weiner DH, Yusuf S. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702–1707
  78. McDonagh TA, Robb SD, Murdoch DR. Biochemical detection of left-ventricular systolic dysfunction. Lancet. 1998;351:9–13
  79. Lerman A, Gibbons RJ, Rodeheffer RJ. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet. 1993;341:1105–1109
  80. Tsutamoto T, Wada A, Maeda K. Plasma brain natriuretic peptide level as a biochemical marker of morbidity and mortality in patients with asymptomatic or minimally symptomatic left ventricular dysfunction. Comparison with plasma angiotensin II and endothelin-1. Eur Heart J. 1999;20:1799–1807
  81. Hall C, Rouleau JL, Moye L. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction. Circulation. 1994;89:1934–1942
  82. McDonagh TA, Cunningham AD, Morrison CD. Left ventricular dysfunction, natriuretic peptides and mortality in an urban population. Heart. 2001;:
  83. Troughton RW, Frampton CM, Yandle TG, Espiner EA, Nicholls MG, Richards AM. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 2000;355:1126–1130
  84. Dutka DP, Olivotto I, Ward S. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure. Eur Heart J. 1995;16:1223–1230
  85. Doval HC, Nul DR, Grancelli HO. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. Circulation. 1996;94:3198–3203
  86. Teerlink JR, Jalaluddin M, Anderson S. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. Circulation. 2000;101:40–46
  87. Nolan J, Flapan AD, Capewell S, MacDonald TM, Neilson JM, Ewing DJ. Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. Br Heart J. 1992;67:482–485
  88. Malik M, Camm AJ. Heart rate variability: from facts to fancies. J Am Coll Cardiol. 1993;22:566–568
  89. Hohnloser SH, Klingenheben T, Zabel M, Schroder F, Just H. Intraindividual reproducibility of heart rate variability. PACE. 1992;15:2211–2214
  90. Mortara A, La Rovere MT, Signorini MG. Can power spectral analysis of heart rate variability identify a high risk subgroup of congestive heart failure patients with excessive sympathetic activation? A pilot study before and after heart transplantation. Br Heart J. 1994;71:422–430
  91. Panina G, Khot UN, Nunziata E, Cody RJ, Binkley PF. Role of spectral measures of heart rate variability as markers of disease progression in patients with chronic congestive heart failure not treated with angiotensin-converting enzyme inhibitors. Am Heart J. 1996;131:153–157
  92. Brouwer J, van Veldhuisen DJ, Man in't Veld AJ. Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group. J Am Coll Cardiol. 1996;28:1183–1189
  93. Ponikowski P, Anker SD, Chua TP. Depressed heart rate variability as an independent predictor of death in chronic congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1997;79:1645–1650
  94. Good CB, McDermott L, McCloskey B. Diet and serum potassium in patients on ACE inhibitors. JAMA. 1995;274:538
  95. Cooper HA, Exner DV, Domanski MJ. Light-to-moderate alcohol consumption and prognosis in patients with left ventricular systolic dysfunction. J Am Coll Cardiol. 2000;35:1753–1759
  96. Anker SD, Chua TP, Ponikowski P. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526–534
  97. Anker SD, Ponikowski P, Varney S. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 1997;349:1050–1053
  98. DeBusk R, Drory Y, Goldstein I. Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. Am J Cardiol. 2000;86:175–181
  99. Feenstra J, Grobbee DE, Remme WJ, Stricker BH. Drug-induced heart failure. J Am Coll Cardiol. 1999;33:1152–1162
  100. Eur Heart J. 2001;22:125–135
  101. Kober L, Torp-Pedersen C, Carlsen JE. Effects on mortality by trandolapril after myocardial infarction. N Engl J Med. 1995;333:1670–1676
  102. Flather M, Yusuf S, Kober L. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative Group. Lancet. 2000;355:1575–1581
  103. Lancet. 1993;342:821–828
  104. Konstam MA, Rousseau MF, Kronenberg MW. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. Circulation. 1992;86:431–438
  105. Greenberg B, Quinones MA, Koilpillai C. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. Circulation. 1995;91:2573–2581
  106. Konstam MA, Patten RD, Thomas I. Effects of losartan and captopril on left ventricular volumes in elderly patients with heart failure: results of the ELITE ventricular function substudy. Am Heart J. 2000;139:1081–1087
  107. Umemura K, Nakashima M, Saruta T. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors. Life Sci. 1997;60:1583–1588
  108. Ljungman S, Kjekshus J, Swedberg K. Renal function in severe congestive heart failure during treatment with enalapril (the Cooperative North Scandinavian Enalapril Survival Study [CONSENSUS] Trial). Am J Cardiol. 1992;70:479–487
  109. Packer M, Poole-Wilson PA, Armstrong PW. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999;100:2312–2318
  110. Kaddoura S, Patel D, Parameshwar J. Objective assessment of the response to treatment of severe heart failure using a 9-minute walk test on a patient-powered treadmill. J Card Fail. 1996;2:133–139
  111. Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17–22
  112. Vargo DL, Kramer WG, Black PK, Smith WB, Serpas T, Brater DC. Bioavailability, pharmacokinetics, and pharmacodynamics of torasemide and furosemide in patients with congestive heart failure. Clin Pharmacol Ther. 1995;57:601–609
  113. Channer KS, McLean KA, Lawson-Matthew P, Richardson M. Combination diuretic treatment in severe heart failure: a randomised controlled trial. Br Heart J. 1994;71:146–150
  114. van Vliet AA, Donker AJ, Nauta JJ, Verheugt FW. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin-converting enzyme inhibitor. Am J Cardiol. 1993;71:21A–8A
  115. Edmonds CJ, Jasani B. Total-body potassium in hypertension patients during prolonged diuretic therapy. Lancet. 1972;2:8–12
  116. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980;44:117–133
  117. Anderson J, Lutz JR, Gilbert EM, Sorensen SG, Yanowitz FG, Menlove RLBM. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol. 1985;55:471–475
  118. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RM. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial. Circulation. 1985;72:536–546
  119. Waagstein F, Bristow MR, Swedberg K. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1993;342:1441–1446
  120. Circulation. 1994;90:1765–1773
  121. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med. 1996;334:1349–1355
  122. Colucci WS, Packer M, Bristow MR. Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. Circulation. 1996;94:2800–2806
  123. Bristow MR, Gilbert EM, Abraham WT. Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. Circulation. 1996;94:2807–2816
  124. Lancet. 1997;349:375–380
  125. Lancet. 1999;353:9–13
  126. Lancet. 1999;353:2001–2007
  127. Circulation. 2000;101:378–384
  128. The Beta-blocker Evaluation of Survival Trial investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med. 2001;344:1659–1667
  129. Doughty RN, Whalley GA, Gamble G, MacMahon S, Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol. 1997;29:1060–1066
  130. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation. 2000;102:546–551
  131. Wang W. Chronic administration of aldosterone depresses baroreceptor reflex function in the dog. Hypertension. 1994;24:571–575
  132. MacFadyen RJ, Barr CS, Struthers AD. Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients. Cardiovasc Res. 1997;35:30–34
  133. Staessen J, Lijnen P, Fagard P, Verschueren LJ, Amery A. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol. 1981;91:457–465
  134. Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and morality in patients with severe heart failure. N Engl J Med. 1999;341:709–717
  135. Burnier M, Brunner HR. Angiotensin II receptor antagonists. Lancet. 2000;355:637–645
  136. Pitt B, Segal R, Martinez FA. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747–752
  137. Pitt B, Poole-Wilson PA, Segal R, Martinez FA, Dickstein K, Camm AJ. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial–the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000;355:1582–1587
  138. Cohn JN, Tognoni G, Glazer RD, Spormann D, Hester A. Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure. J Card Fail. 1999;5:155–160
  139. Khand AU, Rankin AC, Kaye GC, Cleland JG. Systematic review of the management of atrial fibrillation in patients with heart failure. Eur Heart J. 2000;21:614–632
  140. Khand AU, Rankin AC, Martin W, Taylor J, Cleland JGF. Digoxin or carvedilol for the treatment of atrial fibrillation in patients with heart failure? (Abstr). Heart. 2000;83:30
  141. N Engl J Med. 1997;336:525–533
  142. Cohn JN, Johnson G, Ziesche S. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303–310
  143. Cohn JN, Archibald DG, Phil M. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a veterans administration cooperation study. N Engl J Med. 1986;314:1547–1552
  144. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med. 1987;317:799–804
  145. Gogia H, Mehra A, Parikh S. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure. J Am Coll Cardiol. 1995;26:1575–1580
  146. Cohn JN, Ziesche S, Smith R. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-HeFT III. Vasodilator-Heart Failure Trial (V-HeFT) Study Group. Circulation. 1997;96:856–863
  147. Thackray S, Witte K, Clark AL, Cleland JG. Clinical trials update: OPTIME-CHF, PRAISE-2, ALL-HAT. Eur J Heart Fail. 2000;2:209–212
  148. Jones CG, Cleland JG. Meeting report–The LIDO, HOPE, MOXCON and WASH studies. Heart Outcomes Prevention Evaluation. The Warfarin/Aspirin Study of Heart Failure. Eur J Heart Fail. 1999;1:425–431
  149. Gomes UC, Cleland JG. Heart failure update. Eur J Heart Fail. 1999;1:301–302
  150. Hampton JR, van Veldhuisen DJ, Kleber FX. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Lancet. 1997;349:971–977
  151. Cleland JG, Cowburn PJ, Falk RH. Should all patients with atrial fibrillation receive warfarin? Evidence from randomized clinical trials. Eur Heart J. 1996;17:674–681
  152. Loh E, Sutton MS, Wun CC. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251–257
  153. Cleland JG, Massie BM, Packer M. Sudden death in heart failure: vascular or electrical? Eur J Heart Fail. 1999;1:41–45
  154. Ann Intern Med. 1992;116:1–5
  155. Arch Intern Med. 1994;154:1449–1457
  156. Cleland JG. Anticoagulant and antiplatelet therapy in heart failure. Curr Opin Cardiol. 1997;12:276–287
  157. Samama MM, Cohen AT, Darmon JY. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. N Engl J Med. 1999;341:793–800
  158. Steinbeck G, Andresen D, Bach P. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med. 1992;327:987–992
  159. Levy S, Breithardt G, Campbell RW. Atrial fibrillation: current knowledge and recommendations for management. Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J. 1998;19:1294–1320
  160. Singh SN, Fletcher RD, Fisher SG. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med. 1995;333:77–82
  161. Torp-Pedersen C, Moller M, Bloch-Thomsen PE. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. N Engl J Med. 1999;341:857–865
  162. Haque WA, Boehmer J, Clemson BS, Leuenberger UA, Silber DH, Sinoway LI. Hemodynamic effects of supplemental oxygen administration in congestive heart failure. J Am Coll Cardiol. 1996;27:353–357
  163. Neff TA, Petty TL. Long-term continuous oxygen therapy in chronic airway obstruction. Mortality in relationship to cor pulmonale, hypoxia, and hypercapnia. Ann Intern Med. 1970;72:621–626
  164. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211–221
  165. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiography during infusion of dobutamine for identification of reversibly dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617–626
  166. Argenziano M, Spotnitz HM, Whang W, Bigger JT, Parides M, Rose EA. Risk stratification for coronary bypass surgery in patients with left ventricular dysfunction. Analysis of the Coronary Artery Bypass Graft Patch Trial Database. Circulation. 1999;100:II-119–II-124
  167. Antunes PE, Ferrao de Oliveira J, Antunes MJ. Non-cardioplegic coronary surgery in patients with severe left ventricular dysfunction. Eur J Cardiothorac Surg. 1999;16:331–336
  168. Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 1195;109:676–683
  169. Bolling SF, Pagani FD, Deeb GM, Bach DS. Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg. 1998;115:381–386
  170. McCarthy JF, McCarthy PM, Starling RC. Partial left ventriculectomy and mitral valve repair for end-stage congestive heart failure. Eur J Cardiothorac Surg. 1998;13:337–343
  171. Franco-Cereceda A, McCarthy PM, Blackstone EH. Partial left ventriculectomy for dilated cardiomyopathy: is this an alternative to transplantation? J Thorac Cardiovasc Surg. 2001;121:879–893
  172. Alpert MA, Curtis JJ, Sanfelippo JF. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. J Am Coll Cardiol. 1986;7:925–932
  173. Alpert MA, Curtis JJ, Sanfelippo JF. Comparative survival following permanent ventricular and dual-chamber pacing for patients with chronic symptomatic sinus node dysfunction with and without congestive heart failure. Am Heart J. 1987;113:958–965
  174. Cazeau S, Ritter P, Lazarus A. Multisite pacing for end-stage heart failure: early experience. Pacing Clin Electrophysiol. 1996;19:1748–1757
  175. Auricchio A, Stellbrink C, Block M. Effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure. The Pacing Therapies for Congestive Heart Failure Study Group. The Guidant Congestive Heart Failure Research Group. Circulation. 1999;99:2993–3001
  176. Gras D, Mabo P, Tang T. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol. 1998;21:2249–2255
  177. Moss AJ, Hall WJ, Cannom DS. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933–1940
  178. N Engl J Med. 1997;337:1576–1583
  179. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. N Engl J Med. 1999;341:1882–1890
  180. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report–1999. J Heart Lung Transplant. 1999;18:611–626
  181. Paris W, Woodbury A, Thompson S. Returning to work after heart transplantation. J Heart Lung Transplant. 1993;12:46–53
  182. Rimondini A, Cipolla CM, Della Bella P. Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med. 1987;83:43–48
  183. Dormans TP, Huige RM, Gerlag PG. Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide. Heart. 1996;75:349–351
  184. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation. 1985;72:853–864
  185. Opasich C, Febo O, Riccardi PG. Concomitant factors of decompensation in chronic heart failure. Am J Cardiol. 1996;78:354–357
  186. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190–1195
  187. Stewart S, Pearson S, Horowitz JD. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 1998;158:1067–1072
  188. Weinberger M, Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? Veterans Affairs Cooperative Study Group on Primary Care and Hospital Readmission. N Engl J Med. 1996;334:1441–1447
  189. Ekman I, Andersson B, Ehnfors M, Matejka G, Persson B, Fagerberg B. Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. Eur Heart J. 1998;19:1254–1260
  190. Jaarsma T, Halfens R, Huijer Abu-Saad H. Effects of education and support on self-care and resource utilization in patients with heart failure. Eur Heart J. 1999;20:673–682
  191. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41
  192. N Engl J Med. 1987;316:1429–1435
  193. N Engl J Med. 1991;325:293–302
  194. Pfeffer MA, Braunwald E, Moye LA. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. N Engl J Med. 1992;327:669–677
  195. The CAPRICORN Investigators. Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357:1385–1390
  196. Packer M, Coats AJS, Fowler MB. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651–1658

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 HeartHome page
P A Mehta, S W Dubrey, H F McIntyre, D M Walker, S M C Hardman, G C Sutton, T A McDonagh, and M. R Cowie
Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK
Heart, November 15, 2009; 95(22): 1851 - 1856.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
J. B. Somaratne, C. Berry, J. J.V. McMurray, K. K. Poppe, R. N. Doughty, and G. A. Whalley
The prognostic significance of heart failure with preserved left ventricular ejection fraction: a literature-based meta-analysis
Eur J Heart Fail, September 1, 2009; 11(9): 855 - 862.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
E. Agricola, A. Ielasi, M. Oppizzi, P. Faggiano, L. Ferri, A. Calabrese, E. Vizzardi, O. Alfieri, and A. Margonato
Long-term prognosis of medically treated patients with functional mitral regurgitation and left ventricular dysfunction
Eur J Heart Fail, June 1, 2009; 11(6): 581 - 587.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. Nieuwlaat, L. W. Eurlings, J. G. Cleland, S. M. Cobbe, P. E. Vardas, A. Capucci, J. L. Lopez-Sendon, J. G. Meeder, Y. M. Pinto, and H. J.G.M. Crijns
Atrial fibrillation and heart failure in cardiology practice: reciprocal impact and combined management from the perspective of atrial fibrillation: results of the Euro Heart Survey on atrial fibrillation.
J. Am. Coll. Cardiol., May 5, 2009; 53(18): 1690 - 1698.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
S. Boveda, E. Marijon, S. Jacob, P. Defaye, J. B. Winter, A. Bulava, D. Gras, J. P. Albenque, N. Combes, D. Pavin, et al.
Incidence and prognostic significance of sustained ventricular tachycardias in heart failure patients implanted with biventricular pacemakers without a back-up defibrillator: results from the prospective, multicentre, Mona Lisa cohort study
Eur. Heart J., May 2, 2009; 30(10): 1237 - 1244.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
J. Farkas, S. Nabb, L. Zaletel-Kragelj, J. G.F. Cleland, and M. Lainscak
Self-rated health and mortality in patients with chronic heart failure
Eur J Heart Fail, May 1, 2009; 11(5): 518 - 524.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Kubanek, K. M. Goode, V. Lanska, A. L. Clark, and J. G.F. Cleland
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction
Eur J Heart Fail, April 1, 2009; 11(4): 367 - 377.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
M. J Calvert, A. Shankar, R. J McManus, R. Ryan, and N. Freemantle
Evaluation of the management of heart failure in primary care
Fam. Pract., April 1, 2009; 26(2): 145 - 153.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
M. A. ALZadjali, V. Godfrey, F. Khan, A. Choy, A. S. Doney, A. K. Wong, J. R. Petrie, A. D. Struthers, and C. C. Lang
Insulin resistance is highly prevalent and is associated with reduced exercise tolerance in nondiabetic patients with heart failure.
J. Am. Coll. Cardiol., March 3, 2009; 53(9): 747 - 753.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
M. Shafazand, M. Schaufelberger, G. Lappas, K. Swedberg, and A. Rosengren
Survival trends in men and women with heart failure of ischaemic and non-ischaemic origin: data for the period 1987-2003 from the Swedish Hospital Discharge Registry
Eur. Heart J., March 2, 2009; 30(6): 671 - 678.
[Abstract] [Full Text] [PDF]

Home page
 Circ Heart FailHome page
V. V. Georgiopoulou, A. P. Kalogeropoulos, G. Giamouzis, S. A. Agha, M. A. Rashad, S. Waheed, S. Laskar, A. L. Smith, and J. Butler
Digoxin Therapy Does Not Improve Outcomes in Patients With Advanced Heart Failure on Contemporary Medical Therapy
Circ Heart Fail, March 1, 2009; 2(2): 90 - 97.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Baumhakel, U. Muller, and M. Bohm
Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study
Eur J Heart Fail, March 1, 2009; 11(3): 299 - 303.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
I. L. Pina and C. O'Connor
BNP-Guided Therapy for Heart Failure
JAMA, January 28, 2009; 301(4): 432 - 434.
[Full Text] [PDF]

Home page
 AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
W. Chodzko-Zajko, A. Schwingel, and Chae Hee Park
Successful Aging: The Role of Physical Activity
American Journal of Lifestyle Medicine, January 1, 2009; 3(1): 20 - 28.
[Abstract] [PDF]

Home page
 Eur J Heart FailHome page
K. Swedberg
What should we do about heart failure: challenges for 2009
Eur J Heart Fail, January 1, 2009; 11(1): 1 - 2.
[Full Text] [PDF]

Home page
 Eur J Heart FailHome page
P. de Groote, R. Isnard, P. Clerson, G. Jondeau, M. Galinier, P. Assyag, N. Demil, A. Ducardonnet, J.-F. Thebaut, and M. Komajda
Improvement in the management of chronic heart failure since the publication of the updated guidelines of the European Society of Cardiology: The Impact-Reco Programme
Eur J Heart Fail, January 1, 2009; 11(1): 85 - 91.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
A. Boccanelli, G. F. Mureddu, G. Cacciatore, F. Clemenza, A. Di Lenarda, A. Gavazzi, M. Porcu, R. Latini, D. Lucci, A. P. Maggioni, et al.
Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results
Eur J Heart Fail, January 1, 2009; 11(1): 68 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
A. Cohen-Solal, J. J.V. McMurray, K. Swedberg, M. A. Pfeffer, M. Puu, S. D. Solomon, E. L. Michelson, S. Yusuf, C. B. Granger, and for the CHARM Investigators
Benefits and safety of candesartan treatment in heart failure are independent of age: insights from the Candesartan in Heart failure--Assessment of Reduction in Mortality and morbidity programme
Eur. Heart J., December 2, 2008; 29(24): 3022 - 3028.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
S. Stork, H. W. Hense, C. Zentgraf, I. Uebelacker, R. Jahns, G. Ertl, and C. E. Angermann
Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure A prospective cohort study
Eur J Heart Fail, December 1, 2008; 10(12): 1236 - 1245.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. E.A. Blair, F. Zannad, M. A. Konstam, T. Cook, B. Traver, J. C. Burnett Jr, L. Grinfeld, H. Krasa, A. P. Maggioni, C. Orlandi, et al.
Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure: Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program
J. Am. Coll. Cardiol., November 11, 2008; 52(20): 1640 - 1648.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
P. A. Mehta, S. W. Dubrey, H. F. McIntyre, D. M. Walker, S. M.C. Hardman, G. C. Sutton, T. A. McDonagh, and M. R. Cowie
Mode of death in patients with newly diagnosed heart failure in the general population
Eur J Heart Fail, November 1, 2008; 10(11): 1108 - 1116.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
Authors/Task Force Members, K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur. Heart J., October 1, 2008; 29(19): 2388 - 2442.
[Full Text] [PDF]

Home page
 Eur J Heart FailHome page
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. J.V. McMurray, P. Ponikowski, P. A. Poole-Wilson, A. Stromberg, D. J. van Veldhuisen, D. Atar, A. W. Hoes, et al.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)
Eur J Heart Fail, October 1, 2008; 10(10): 933 - 989.
[Full Text] [PDF]

Home page
 Eur J Heart FailHome page
P. Johansson, A. Brostrom, U. Dahlstrom, and U. Alehagen
Global perceived health and ten-year cardiovascular mortality in elderly primary care patients with possible heart failure
Eur J Heart Fail, October 1, 2008; 10(10): 1040 - 1047.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
M. J. Crespo, N. Cruz, P. I. Altieri, and N. Escobales
Enalapril and Losartan Are More Effective Than Carvedilol in Preventing Dilated Cardiomyopathy in the Syrian Cardiomyopathic Hamster
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2008; 13(3): 199 - 206.
[Abstract] [PDF]

Home page
 Eur J Heart FailHome page
A. A. Schiffer, S. S. Pedersen, J. W. Widdershoven, and J. Denollet
Type D personality and depressive symptoms are independent predictors of impaired health status in chronic heart failure
Eur J Heart Fail, September 1, 2008; 10(9): 922 - 930.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
A. A. Schiffer, S. S. Pedersen, J. W. Widdershoven, and J. Denollet
Type D personality and depressive symptoms are independent predictors of impaired health status in chronic heart failure
Eur J Heart Fail, August 1, 2008; 10(8): 802 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
W. J. Remme, J. J.V. McMurray, F.D. R. Hobbs, A. Cohen-Solal, J. Lopez-Sendon, A. Boccanelli, F. Zannad, B. Rauch, K. Keukelaar, C. Macarie, et al.
Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians
Eur. Heart J., July 2, 2008; 29(14): 1739 - 1752.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
D. Moertl, A. Hammer, M. Huelsmann, R. Pacher, and R. Berger
Prognostic value of sequential measurements of amino-terminal prohormone of B-type natriuretic peptide in ambulatory heart failure patients
Eur J Heart Fail, April 1, 2008; 10(4): 404 - 411.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EchocardiogrHome page
E. Donal, M. Roulaud, P. Raud-Raynier, C. De Bisschop, C. Leclercq, G. Derumeaux, J.-C. Daubert, P. Mabo, and A. Denjean
Echocardiographic right ventricular strain analysis in chronic heart failure
Eur J Echocardiogr, December 1, 2007; 8(6): 449 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
W. J. Remme
Filling the gap between guidelines and clinical practice in heart failure treatment -- Still a far cry from reality
Eur J Heart Fail, December 1, 2007; 9(12): 1143 - 1145.
[Full Text] [PDF]

Home page
 Eur J Heart FailHome page
P. de Groote, R. Isnard, P. Assyag, P. Clerson, A. Ducardonnet, M. Galinier, G. Jondeau, I. Leurs, J.-F. Thebaut, and M. Komajda
Is the gap between guidelines and clinical practice in heart failure treatment being filled? Insights from the IMPACT RECO survey
Eur J Heart Fail, December 1, 2007; 9(12): 1205 - 1211.
[Abstract] [Full Text] [PDF]

Home page
 Fam PractHome page
T Fahey, S Jeyaseelan, C McCowan, E Carr, B. Goudie, S. Pringle, P. Donnan, F. Sullivan, and A. Struthers
Diagnosis of left ventricular systolic dysfunction (LVSD): development and validation of a clinical prediction rule in primary care
Fam. Pract., December 1, 2007; 24(6): 628 - 635.
[Abstract] [Full Text] [PDF]

Home page
 J Clin PharmacolHome page
S. E. Shoaf, Z. Wang, P. Bricmont, and S. Mallikaarjun
Pharmacokinetics, Pharmacodynamics, and Safety of Tolvaptan, a Nonpeptide AVP Antagonist, During Ascending Single-Dose Studies in Healthy Subjects
J. Clin. Pharmacol., December 1, 2007; 47(12): 1498 - 1507.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
I.S. Thrainsdottir, T. Aspelund, V. Gudnason, K. Malmberg, G. Sigurdsson, G. Thorgeirsson, T. Hardarson, and L. Ryden
Increasing glucose levels and BMI predict future heart failure Experience from the Reykjavik Study
Eur J Heart Fail, October 1, 2007; 9(10): 1051 - 1057.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. Duckelmann, F. Mittermayer, D. G. Haider, J. Altenberger, J. Eichinger, and M. Wolzt
Asymmetric Dimethylarginine Enhances Cardiovascular Risk Prediction in Patients With Chronic Heart Failure
Arterioscler Thromb Vasc Biol, September 1, 2007; 27(9): 2037 - 2042.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
T. Breidthardt, M. Christ, M. Matti, D. Schrafl, K. Laule, M. Noveanu, T. Boldanova, T. Klima, W. Hochholzer, A. P Perruchoud, et al.
QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure
Heart, September 1, 2007; 93(9): 1093 - 1097.
[Abstract] [Full Text] [PDF]

Home page
 ptjournalHome page
A. R. Lindquist, C. L Prado, R. M. Barros, R. Mattioli, P. H L. da Costa, and T. F Salvini
Gait Training Combining Partial Body-Weight Support, a Treadmill, and Functional Electrical Stimulation: Effects on Poststroke Gait
Physical Therapy, September 1, 2007; 87(9): 1144 - 1154.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
T. Breidthardt, K. Laule, A.-H. Strohmeyer, C. Schindler, S. Meier, M. Fischer, A. Scholer, M. Noveanu, M. Christ, A. P. Perruchoud, et al.
Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea
Clin. Chem., August 1, 2007; 53(8): 1415 - 1422.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
P. W F B.-A. de la Porte, D. J A Lok, D. J van Veldhuisen, J. van Wijngaarden, J. H Cornel, N. P A Zuithoff, E. Badings, and A. W Hoes
Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study
Heart, July 1, 2007; 93(7): 819 - 825.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
R. Pirracchio, B. Cholley, S. De Hert, A. C. Solal, and A. Mebazaa
Diastolic heart failure in anaesthesia and critical care
Br. J. Anaesth., June 1, 2007; 98(6): 707 - 721.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
M. Postorino, C. Marino, G. Tripepi, C. Zoccali, and on behalf of the Calabrian Registry of Dialysis an
Prognostic value of the New York Heart Association classification in end-stage renal disease
Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1377 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
N. K. Khan, K. M. Goode, J. G.F. Cleland, A. S. Rigby, N. Freemantle, J. Eastaugh, A. L. Clark, R. de Silva, M. J. Calvert, K. Swedberg, et al.
Prevalence of ECG abnormalities in an international survey of patients with suspected or confirmed heart failure at death or discharge
Eur J Heart Fail, May 1, 2007; 9(5): 491 - 501.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
P. Jourdain, G. Jondeau, F. Funck, P. Gueffet, A. Le Helloco, E. Donal, J. F. Aupetit, M. C. Aumont, M. Galinier, J. C. Eicher, et al.
Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure: The STARS-BNP Multicenter Study
J. Am. Coll. Cardiol., April 24, 2007; 49(16): 1733 - 1739.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Cicoira, A. P. Maggioni, R. Latini, S. Barlera, E. Carretta, A. Janosi, J. S. Soler, I. Anand, J. N. Cohn, and Val-HeFT Investigators
Body mass index, prognosis and mode of death in chronic heart failure: Results from the Valsartan Heart Failure Trial
Eur J Heart Fail, April 1, 2007; 9(4): 397 - 402.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. S. Pagel
Levosimendan in Cardiac Surgery: A Unique Drug for the Treatment of Perioperative Left Ventricular Dysfunction or Just Another Inodilator Searching for a Clinical Application?
Anesth. Analg., April 1, 2007; 104(4): 759 - 761.
[Full Text] [PDF]

Home page
 CMAJHome page
L. A. Allen and C. M. O'Connor
Management of acute decompensated heart failure
Can. Med. Assoc. J., March 13, 2007; 176(6): 797 - 805.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
F. Najafi, A. J. Dobson, and K. Jamrozik
Recent changes in heart failure hospitalisations in Australia
Eur J Heart Fail, March 1, 2007; 9(3): 228 - 233.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
A J Turley, A P Roberts, A Davies, N Rowell, J Drury, R H Smith, A Shyam-Sundar, and M J Stewart
NT-proBNP and the diagnosis of left ventricular systolic dysfunction within two acute NHS trust catchment areas: the initial Teesside experience
Postgrad. Med. J., March 1, 2007; 83(977): 206 - 208.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
K. McDonald, C. Conlon, and M. Ledwidge
Disease management programs for heart failure: Not just for the 'sick' heart failure population
Eur J Heart Fail, February 1, 2007; 9(2): 113 - 117.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. von Haehling, W. Doehner, and S. D Anker
Nutrition, metabolism, and the complex pathophysiology of cachexia in chronic heart failure
Cardiovasc Res, January 15, 2007; 73(2): 298 - 309.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al.
Recommendations on the use of exercise testing in clinical practice
Eur. Respir. J., January 1, 2007; 29(1): 185 - 209.
[Abstract] [Full Text] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
H. Hegazy, A. Refaei, A. Assedique, S. Alsaif, M. Taha, M. Refaei, N. Elkum, H. Alomran, and Z. Al-Halees
PET scan before CABG in diabetes
The British Journal of Diabetes & Vascular Disease, January 1, 2007; 7(1): 32 - 37.
[Abstract] [PDF]

Home page
 Eur J Heart FailHome page
S. Jeyaseelan, B. M. Goudie, S. D. Pringle, P. T. Donnan, F. M. Sullivan, and A. D. Struthers
A critical re-appraisal of different ways of selecting ambulatory patients with suspected heart failure for echocardiography
Eur J Heart Fail, January 1, 2007; 9(1): 55 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Kubanek, I. Malek, J. Bytesnik, P. Fridl, L. Riedlbauchova, L. Karasova, V. Lanska, and J. Kautzner
Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months
Eur J Heart Fail, December 1, 2006; 8(8): 832 - 840.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
B. A.F. van Tol, R. J. Huijsmans, D. W. Kroon, M. Schothorst, and G. Kwakkel
Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta-analysis
Eur J Heart Fail, December 1, 2006; 8(8): 841 - 850.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
K. Falk, K. Swedberg, F. Gaston-Johansson, and I. Ekman
Fatigue and anaemia in patients with chronic heart failure
Eur J Heart Fail, November 1, 2006; 8(7): 744 - 749.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
E. A. Jankowska, B. Biel, J. Majda, A. Szklarska, M. Lopuszanska, M. Medras, S. D. Anker, W. Banasiak, P. A. Poole-Wilson, and P. Ponikowski
Anabolic Deficiency in Men With Chronic Heart Failure: Prevalence and Detrimental Impact on Survival
Circulation, October 24, 2006; 114(17): 1829 - 1837.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
R. R.J. van Kimmenade, J. L. Januzzi Jr, A. L. Baggish, J. G. Lainchbury, A. Bayes-Genis, A. M. Richards, and Y. M. Pinto
Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure: Redefining the Cardiorenal Interaction?
J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1621 - 1627.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. D. Pagani, J. W. Long, W. P. Dembitsky, L. D. Joyce, and L. W. Miller
Improved Mechanical Reliability of the HeartMate XVE Left Ventricular Assist System.
Ann. Thorac. Surg., October 1, 2006; 82(4): 1413 - 1418.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
R. J. Shelton, A. L. Clark, K. Goode, A. S. Rigby, and J. G.F. Cleland
The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation
Eur. Heart J., October 1, 2006; 27(19): 2353 - 2361.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
L. C. van Vark, I. Kardys, G. S. Bleumink, A. M. Knetsch, J. W. Deckers, A. Hofman, B. H.Ch. Stricker, and J. C.M. Witteman
Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam Study
Eur. Heart J., October 1, 2006; 27(19): 2346 - 2352.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Herrmann, O. Taban-Shomal, U. Hubner, M. Bohm, and W. Herrmann
A review of homocysteine and heart failure
Eur J Heart Fail, October 1, 2006; 8(6): 571 - 576.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
I. Lesman-Leegte, T. Jaarsma, R. Sanderman, G. Linssen, and D. J. van Veldhuisen
Depressive symptoms are prominent among elderly hospitalised heart failure patients
Eur J Heart Fail, October 1, 2006; 8(6): 634 - 640.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J D Newton and I B Squire
Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure
Heart, October 1, 2006; 92(10): 1441 - 1446.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
N. Aspromonte, V. Ceci, A. Chiera, C. Coletta, A. D'Eri, M. Feola, P. Giovinazzo, L. Milani, F. Noventa, A. B. Scardovi, et al.
Rapid Brain Natriuretic Peptide Test and Doppler Echocardiography for Early Diagnosis of Mild Heart Failure
Clin. Chem., September 1, 2006; 52(9): 1802 - 1808.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
J N Tenkorang, K F Fox, T J Collier, and D A Wood
A rapid access cardiology service for chest pain, heart failure and arrhythmias accurately diagnoses cardiac disease and identifies patients at high risk: a prospective cohort study
Heart, August 1, 2006; 92(8): 1084 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
A. Ahmed, I. B. Aban, M. T. Weaver, W. S. Aronow, and J. L. Fleg
Serum digoxin concentration and outcomes in women with heart failure: A bi-directional effect and a possible effect modification by ejection fraction
Eur J Heart Fail, June 1, 2006; 8(4): 409 - 419.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
L Grigorian Shamagian, A Varela Roman, J M Garcia-Acuna, P Mazon Ramos, A Virgos Lamela, and J R Gonzalez-Juanatey
Anaemia is associated with higher mortality among patients with heart failure with preserved systolic function
Heart, June 1, 2006; 92(6): 780 - 784.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
N P Nikitin, P H Loh, R de Silva, J Ghosh, O Y Khaleva, K Goode, A S Rigby, F Alamgir, A L Clark, and J G F Cleland
Prognostic value of systolic mitral annular velocity measured with Doppler tissue imaging in patients with chronic heart failure caused by left ventricular systolic dysfunction
Heart, June 1, 2006; 92(6): 775 - 779.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart J SupplHome page
C. Funck-Brentano
Beta-blockade in CHF: from contraindication to indication
Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C19 - C27.
[Abstract] [Full Text] [PDF]

Home page
 Arch Intern MedHome page
C. Mueller, K. Laule-Kilian, C. Schindler, T. Klima, B. Frana, D. Rodriguez, A. Scholer, M. Christ, and A. P. Perruchoud
Cost-effectiveness of B-Type Natriuretic Peptide Testing in Patients With Acute Dyspnea.
Arch Intern Med, May 22, 2006; 166(10): 1081 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
L. Tavazzi, A. P. Maggioni, D. Lucci, G. Cacciatore, G. Ansalone, F. Oliva, M. Porcu, and on behalf of the Italian survey on Acute Heart Fai
Nationwide survey on acute heart failure in cardiology ward services in Italy
Eur. Heart J., May 2, 2006; 27(10): 1207 - 1215.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
M D Thomas, K F Fox, D A Wood, J S R Gibbs, A J S Coats, M Y Henein, P A Poole-Wilson, and G C Sutton
Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function
Heart, May 1, 2006; 92(5): 603 - 608.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
K Komamura, T Sasaki, A Hanatani, J Kim, K Hashimura, Y Ishida, Y Ohkaru, K Asayama, T Tanaka, A Ogai, et al.
Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy
Heart, May 1, 2006; 92(5): 615 - 618.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
P A Mehta and M R Cowie
Gender and heart failure: a population perspective
Heart, May 1, 2006; 92(suppl_3): iii14 - iii18.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. S Schleithoff, A. Zittermann, G. Tenderich, H. K Berthold, P. Stehle, and R. Koerfer
Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 754 - 759.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
H. P. B.-L. Rocca, J. Capraro, and W. Kiowski
Compliance by Referring Physicians With Recommendations on Heart Failure Therapy from a Tertiary Center
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2006; 11(1): 85 - 92.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
R. de Silva, N. P. Nikitin, K. K.A. Witte, A. S. Rigby, K. Goode, S. Bhandari, A. L. Clark, and J. G.F. Cleland
Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis
Eur. Heart J., March 1, 2006; 27(5): 569 - 581.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Metra, C. Zani, L. Covolo, S. Nodari, N. Pezzali, U. Gelatti, F. Donato, G. Nardi, and L. D. Cas
Role of {beta}1- and {alpha}2c-adrenergic receptor polymorphisms and their combination in heart failure: A case-control study
Eur J Heart Fail, March 1, 2006; 8(2): 131 - 135.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
M. Lainscak and I. Keber
Patients' knowledge and beta blocker treatment improve prognosis of patients from a heart failure clinic
Eur J Heart Fail, March 1, 2006; 8(2): 187 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Eur J Heart FailHome page
N. H.M.K. Uszko-Lencer, F. Bothmer, P. E.J. van Pol, and A. M.W.J. Schols
Measuring body composition in chronic heart failure: A comparison of methods
Eur J Heart Fail, March 1, 2006; 8(2): 208 - 214.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow An erratum has been published
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Swedberg, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swedberg, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?